FR2855825B1 - Produits aryl-heteroaromatiques, compositions les contenant et utilisation - Google Patents

Produits aryl-heteroaromatiques, compositions les contenant et utilisation

Info

Publication number
FR2855825B1
FR2855825B1 FR0306719A FR0306719A FR2855825B1 FR 2855825 B1 FR2855825 B1 FR 2855825B1 FR 0306719 A FR0306719 A FR 0306719A FR 0306719 A FR0306719 A FR 0306719A FR 2855825 B1 FR2855825 B1 FR 2855825B1
Authority
FR
France
Prior art keywords
aryl
compositions containing
containing same
heteroaromatic products
heteroaromatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0306719A
Other languages
English (en)
Other versions
FR2855825A1 (fr
Inventor
Patrick Mailliet
Brun Alain Le
Fabienne Thompson
Gilles Tiraboschi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to FR0306719A priority Critical patent/FR2855825B1/fr
Priority to ARP040101890A priority patent/AR044586A1/es
Priority to PE2004000556A priority patent/PE20050226A1/es
Priority to GT200400113A priority patent/GT200400113A/es
Priority to KR1020057023192A priority patent/KR20060006850A/ko
Priority to CL200401359A priority patent/CL2004001359A1/es
Priority to EP04767247A priority patent/EP1641765A1/fr
Priority to JP2006508355A priority patent/JP4805813B2/ja
Priority to AU2004245269A priority patent/AU2004245269A1/en
Priority to CA002528093A priority patent/CA2528093A1/fr
Priority to TW093115885A priority patent/TW200510344A/zh
Priority to PCT/FR2004/001379 priority patent/WO2004108685A1/fr
Priority to MXPA05012929A priority patent/MXPA05012929A/es
Priority to CNB2004800218006A priority patent/CN100427472C/zh
Priority to BRPI0411001-3A priority patent/BRPI0411001A/pt
Priority to US10/859,740 priority patent/US20050014765A1/en
Priority to UY28350A priority patent/UY28350A1/es
Priority to PA20048604401A priority patent/PA8604401A1/es
Publication of FR2855825A1 publication Critical patent/FR2855825A1/fr
Priority to IL172222A priority patent/IL172222A0/en
Priority to HK06114181.4A priority patent/HK1093339A1/xx
Application granted granted Critical
Publication of FR2855825B1 publication Critical patent/FR2855825B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
FR0306719A 2003-06-04 2003-06-04 Produits aryl-heteroaromatiques, compositions les contenant et utilisation Expired - Fee Related FR2855825B1 (fr)

Priority Applications (20)

Application Number Priority Date Filing Date Title
FR0306719A FR2855825B1 (fr) 2003-06-04 2003-06-04 Produits aryl-heteroaromatiques, compositions les contenant et utilisation
PE2004000556A PE20050226A1 (es) 2003-06-04 2004-06-02 Productos aril-heteroaromaticos y composiciones que los contienen
GT200400113A GT200400113A (es) 2003-06-04 2004-06-02 Productos aril-heteroaromaticos, composiciones que los contienen y su utilizacion.
ARP040101890A AR044586A1 (es) 2003-06-04 2004-06-02 Productos aril - heteroaromaticos, composiciones que los contienen y su utilizacion
US10/859,740 US20050014765A1 (en) 2003-06-04 2004-06-03 Aryl-heteroaromatic products, compositions comprising them and use
EP04767247A EP1641765A1 (fr) 2003-06-04 2004-06-03 Produits aryl-heteroaromatiques, compositions les contenant et utilisation
JP2006508355A JP4805813B2 (ja) 2003-06-04 2004-06-03 アリール−ヘテロ芳香族生成物、それらを含む組成物及びその使用
AU2004245269A AU2004245269A1 (en) 2003-06-04 2004-06-03 Aryl-heteroaromatic products, compositions containing same and use thereof
CA002528093A CA2528093A1 (fr) 2003-06-04 2004-06-03 Produits aryl-heteroaromatiques, compositions les contenant et utilisation
TW093115885A TW200510344A (en) 2003-06-04 2004-06-03 Aryl-heteroaromatic products, compositions comprising them and use
KR1020057023192A KR20060006850A (ko) 2003-06-04 2004-06-03 아릴-헤테로방향족 생성물, 이를 함유하는 조성물 및 이의용도
MXPA05012929A MXPA05012929A (es) 2003-06-04 2004-06-03 Productos aril-heteroaromaticos, composiciones que los contienen y su utilizacion.
CNB2004800218006A CN100427472C (zh) 2003-06-04 2004-06-03 芳基-杂芳族化合物、含有它们的组合物及其用途
BRPI0411001-3A BRPI0411001A (pt) 2003-06-04 2004-06-03 produtos aril-heteroaromáticos, composições que os contêm e utilização
CL200401359A CL2004001359A1 (es) 2003-06-04 2004-06-03 Compuestos derivados de piperazina, composicion farmaceutica, utiles como agentes inhibidores de polimerizacion de la tubulina, inhibidores de celulas tumorales y para tratar cancer.
PCT/FR2004/001379 WO2004108685A1 (fr) 2003-06-04 2004-06-03 Produits aryl-heteroaromatiques, compositions les contenant et utilisation
UY28350A UY28350A1 (es) 2003-06-04 2004-06-04 Productos aril-heteroaromaticos, composiciones que los contienen y su utilización
PA20048604401A PA8604401A1 (es) 2003-06-04 2004-06-04 Productos aril-heteroaromaticos, composiciones que los contienen y su utilizacion.
IL172222A IL172222A0 (en) 2003-06-04 2005-11-28 Aryl-heteroaromatic products, compositions comprising them and use
HK06114181.4A HK1093339A1 (en) 2003-06-04 2006-12-28 Aryl-heteroaromatic products, compositions containing same and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0306719A FR2855825B1 (fr) 2003-06-04 2003-06-04 Produits aryl-heteroaromatiques, compositions les contenant et utilisation

Publications (2)

Publication Number Publication Date
FR2855825A1 FR2855825A1 (fr) 2004-12-10
FR2855825B1 true FR2855825B1 (fr) 2008-08-22

Family

ID=33443126

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0306719A Expired - Fee Related FR2855825B1 (fr) 2003-06-04 2003-06-04 Produits aryl-heteroaromatiques, compositions les contenant et utilisation

Country Status (3)

Country Link
CN (1) CN100427472C (fr)
FR (1) FR2855825B1 (fr)
GT (1) GT200400113A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI415845B (zh) * 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
CN101607942B (zh) * 2008-06-17 2012-02-22 中国人民解放军第二军医大学 一类抗肿瘤化合物及其制备方法
EP2808324A4 (fr) * 2012-01-25 2015-03-18 Yakult Honsha Kk Composé pyrrole
CN108358864B (zh) * 2017-12-15 2020-07-17 五邑大学 一种2-酰基-5-苯基噁唑类微管蛋白抑制剂的制备方法及应用
CN108707147A (zh) * 2018-06-20 2018-10-26 桑文军 一种新型微管蛋白抑制剂及其在抗肿瘤药物中的应用
CN112521357B (zh) * 2020-08-31 2021-10-08 深圳瑞健生物科技有限公司 一种长效低成瘾性hnk衍生物及其制备方法
CN114195735A (zh) * 2020-09-02 2022-03-18 沈阳药科大学 1,2,3-噻二唑类化合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0820452B1 (fr) * 1995-04-07 2003-06-04 Schering Corporation Composes de piperazinyle et de piperidinyle carbonyles inhibant la transferase de proteine farnesyle
DE10035908A1 (de) * 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
DE10035927A1 (de) * 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
DE10035928A1 (de) * 2000-07-21 2002-03-07 Asta Medica Ag Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel
FR2815032B1 (fr) * 2000-10-10 2003-08-08 Pf Medicament Nouveaux derives d'aminophenyle piperazine ou d'amino phenyle piperide inhibiteurs de proteines prenyl transferase ainsi que leurs preparations
EP1517898A1 (fr) * 2002-06-29 2005-03-30 Zentaris GmbH Aryl- et heteroarylcarbonylpiperazines et leur utilisation dans le traitement de maladies tumorales benignes et malignes

Also Published As

Publication number Publication date
GT200400113A (es) 2005-12-22
CN100427472C (zh) 2008-10-22
FR2855825A1 (fr) 2004-12-10
CN1829697A (zh) 2006-09-06

Similar Documents

Publication Publication Date Title
HK1093339A1 (en) Aryl-heteroaromatic products, compositions containing same and use thereof
FR15C0037I2 (fr) Compositions monodisperses contenant du naloxol pegyle
FR2885904B1 (fr) Nouveaux derives du fluorene, compositions les contenant et utilisation
FR2843023B1 (fr) Compositions cosmetiques ou dermopharmaceutiques contenant du kombucha.
FR2838048B1 (fr) Produit dentaire reticulable/dereticulable
MA29030B1 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
IL173205A0 (en) Aryl heteroaromatic products, compositions comprising the same and use thereof
DK1620118T3 (da) Reversible pegylerede lægemidler
IL173299A (en) 2,4-Pyrimidindiamine derivatives, preparations containing them and their use
PL2218342T3 (pl) Nowe kompozycje nutraceutyczne i ich zastosowanie
SE0202529L (sv) Födoämneskompositionsprodukt
FR2903406B1 (fr) Derives de pyrazolylbenzimidazole,compositions les contenant et utilisation
DK1670769T3 (da) Benzimidazol-derivater, sammensætninger indeholdende disse, fremstilling deraf og anvendelser deraf
HUP0500871A3 (en) 5-aryltetrazole compounds, compositions thereof and their use
IL170080A (en) Nucleic acid and protein known as 158p1d7 and their pharmaceutical preparations
IL197887A0 (en) New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90
FR2855825B1 (fr) Produits aryl-heteroaromatiques, compositions les contenant et utilisation
FR2857363B1 (fr) 4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c] pyridines substituees compositions les contenant et utilisation
FR2850379B1 (fr) Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation
MA27351A1 (fr) 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
FR2901554B1 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation
FR2835431B1 (fr) COMPOSITION COSMETIQUE CONTENANT UNE Nx,Ng-DIACYLARGININE
DK1691751T3 (da) Hygiejneprodukt
FR2833004B1 (fr) Aryl-cycloalcaines substitues, compositions les contenant et utilisation

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130228